Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma
Clinical trial NCT01858558 · COMPLETED
Trial details
- NCT number
- NCT01858558
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2019-06-19
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.